|
| 1 |
Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma
Hae-Sim Park, Sang Haak Lee, Sook Young Lee, Mi-Kyeong Kim, Byung Jae Lee, Viktoria Werkström, Peter Barker, James G. Zangrilli
|
|
| 2 |
Higher Binding Affinity and In Vitro Potency of Reslizumab for Interleukin-5 Compared With Mepolizumab
Mark Liddament, Jean Husten, Tanya Estephan, David Laine, David Mabon, Laurie Pukac, Jacquelyn Lyons, Adam W. Clarke, Anthony Doyle
|
|
| 3 |
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Michael Dreher, Tobias Müller
|
|
| 4 |
Interleukin-10 and interleukin-5 balance in patients with active asthma, those in remission, and healthy controls
Minako Tomiita, Eduardo Campos-Alberto, Masayuki Shima, Masanobu Namiki, Kazuo Sugimoto, Hiroyuki Kojima, Hiroko Watanabe, Kunio Sekine, Toshiyuki Nishimuta, Yoichi Kohno, Naoki Shimojo
|
|
| 5 |
Serial Changes in Serum Eosinophil-associated Mediators between Atopic and Non-atopic Children after Mycoplasma pneumoniae pneumonia
Joo-Hwa Kim, Tae-shik Cho, Jin-Hwa Moon, Chang-Ryul Kim, Jae-Won Oh
|
|
| 6 |
Hypereosinophilia-associated Diseases and the Therapeutic Agents in Development
Il Yup Chung
|
|
| 7 |
Mycoplasma pneumoniae Infection Affects the Serum Levels of Vascular Endothelial Growth Factor and Interleukin-5 in Atopic Children
You-Cheol Jeong, Mun-Soo Yeo, Joo-Hwa Kim, Ha-Baik Lee, Jae-Won Oh
|
|
